Cancer prone persons. A randomized screening trial based on colonoscopy: Background, design and recruitment

Familial Cancer

Volumn 1, Issue 3-4, 2001, Pages 175-179

  Eisinger, François ^a   Giordanella, Jean Pierre ^b   Brigand, Alain ^c   Didelot, Remi ^d   Jacques, Dominique ^c   Schenowitz, Gerard ^e   Julian Reynier, Claire ^f   Seitz, Jean François ^g   Sobol, Hagay ^a   Faivre, Jean ^f   Allemand, Hubert ^b  

^a INSTITUT PAOLI CALMETTES   (France)

^b National Health Insurance   (France)

^c Periodic Health Examination Center   (France)

^d Periodic Health Examination Center   (France)

^e CREGG   (France)

^f INSERM   (France)

^g TIMONE HOSPITAL   (France)

Author keywords

Cancer; Colon; Colonoscopy; Genetics; Hereditary; HNPCC; Randomized trial; Screening

Indexed keywords

ADULT; ARTICLE; CANCER RISK; CANCER SCREENING; CANCER SUSCEPTIBILITY; CLINICAL TRIAL; COLON CANCER; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EVIDENCE BASED MEDICINE; FAMILY HISTORY; FRANCE; GENETIC COUNSELING; GENETIC HETEROGENEITY; GENETICS; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; AGED; COLONOSCOPY; COLORECTAL NEOPLASMS; EPIDEMIOLOGIC RESEARCH DESIGN; FEMALE; FRANCE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; MALE; MASS SCREENING; MIDDLE AGED; PATIENT SELECTION; RISK FACTORS;

EID: 0035782761     PISSN: 13899600     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1021177417531     Document Type: Article

References (26)

1. de Vathaire F, Rezvani A, Laplanche A et al. (eds). Estimation de l'Incidence des Cancers en France 1983-1987. Paris: Editions INSERM, 1996.
2. INSERM (ed). Statistiques des Causes Médicales de Décès 1994. Paris: Editions INSERM, 1996.
3. Murday V. Family cancer screening. In Hardcastle JD (eds). Screening for Colorectal Cancer. Bad Homburg: Normed Verlag, 1990, pp. 8-15.
4. Fuchs CS, Giovannucci ED, Colditz GA et al. A prospective study of family history and the risk of colorectal cancer. N Engl J Med 1994; 331: 1669-74.
5. Wijnen JT, Vasen HF, Khan PM et al. Clinical findings with implications for genetic testing in families with clustering of colorectal cancer. N Engl J Med 1998; 339(8): 511-8.
6. Holtzman NA, Murphy PD, Watson MS, Barr PA. Predictive genetic testing: From basic research to clinical practice. Science 1997; 278(5338): 602-5.
7. Harrison TR. Principes de Médecine Interne. 5eme Edition Française Ed. Paris: Flammarion, 1993.
8. Winawer SJ, Zauber AG, May Nah Ho et al. Prevention of colorectal cancer by colonoscopic polypectomy. New Engl J Med 1993, 329: 1977-81.
9. Hardcastle JD, Chamberlain JO, Robinson MH et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996; 348(9040): 1472-7.
10. Kronborg O, Fenger C, Olsen J et al. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996; 348(9040): 1467-71.
11. Burke W, Petersen G, Lynch P et al. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. I. Hereditary nonpolyposis colon cancer. Cancer Genetics Studies Consortium. JAMA 1997; 277: 915-9.
12. Sankila R, Aaltonen LA, Jarvinen HJ, Mecklin JP. Better survival rates in patients with MLH1-associated hereditary colorectal cancer [see comments]. Gastroenterology 1996; 110(3): 682-7.
13. Eisinger F, Noguès C, Birnbaum D et al. Low frequency of lymph-node metastasis in BRCA1-associated breast cancer. Lancet 1998; 351: 1633-4.
14. Tambor ES, Bernhardt BA, Geller G et al. Should women at increased risk for breast and ovarian cancer be randomized to prophylactic surgery? An ethical and empirical assessment. J Womens Health Gend Based Med 2000; 9(3): 223-33.
15. Eisinger F, Giordanella J, Didelot R et al. Pratiques de dépistage et antécédents familiaux de cancer colorectal. Gastroenterol Clin Biol 1996; 20: 627-32.
16. Olschwang S, Laurent-Puig P. Startégie de surveillance des sujets à risque élevé ou très élevé de cancer colorectal. Gastroenterol Clin Biol 1998; 22: s40-3.
17. Jarvinen HJ, Aarnio M, Mustonen H et al. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 2000; 118(5): 829-34.
18. Bond JH. Polyp Guideline: Diagnosis, treatment, and surveillance for patients with nonfamilial colorectal polyps. Ann Intern Med 1993;119:836-43.
19. Vasen HFA, Nagengast FM, Meera Khan P. Interval cancers in hereditary non-polyposis colorectal cancer (Lynch syndrome). Lancet 1995; 345: 1183-4.
20. Vasen HF, Taal BG, Nagengast FM et al. Hereditary nonpolyposis colorectal cancer: Results of long-term surveillance in 50 families. Eur J Cancer 1995; 31A(7-8): 1145-8.
21. Anonymous. Conférence de consensus. Prévention, dépistage et prise en charge des cancers du colon. Gastroenterol Clin Biol 1998; 22: S275-S88.
22. Stephenson BM, Murday VA, Finan PJ et al. Feasibility of family based screening for colorectal neoplasia: Experience in one general surgical practice. Gut 1993; 34: 96-100.
23. Aitken J, Bain C, Ward M et al. How accurate is self-reported family of colorectal cancer. Am J Epidemiol 1995; 141: 863-71.
24. Hudmon KS, Love RR, Chamberlain RM. Perceived benefits of and barriers to participation in phase I/II colon cancer chemoprevention trial. J Cancer Educ 1999; 14(2): 83-7.
25. Hudmon KS, Stoltzfus C, Chamberlain RM et al. Participants' perceptions of a phase I colon cancer chemoprevention trial. Control Clin Trials 1996; 17(6): 494-508.
26. Fisher B, Costantino J, Wickerham D et al. Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-I Study. J Natl Cancer Inst 1998; 90: 1371-88.